Elisabetta Bugianesi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 315 publications
Chicken bone-derived peptides: characterization and effects on human gut microbiota using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®).
Journal: Food & function
Published: August 10, 2026
Reply to "Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis - Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons".
Journal: JHEP reports : innovation in hepatology
Published: July 20, 2026
Erratum: Noninvasive assessment of liver disease severity in NAFLD and T2D.
Journal: Hepatology (Baltimore, Md.)
Published: July 17, 2026
MBOAT7 rs641738 TT genotype is associated with poorer survival in MASLD-related hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: July 07, 2026
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 03, 2026
Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis.
Journal: Clinics in liver disease
Published: May 16, 2026
Implications of new obesity definitions in the classification and outcomes of patients with MASLD.
Journal: Hepatology (Baltimore, Md.)
Published: April 08, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLD.
Journal: Clinical and molecular hepatology
Published: March 04, 2026
The natural history and individualized prediction of liver stiffness-based fibrosis risk in metabolic dysfunction-associated steatotic liver disease.
Journal: Clinical and molecular hepatology
Published: March 04, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trial.
Journal: JHEP reports : innovation in hepatology
Published: February 03, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.
Journal: Cardiovascular diabetology
Published: January 26, 2026
Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.
Journal: JHEP reports : innovation in hepatology
Published: January 20, 2026
Last Updated: 09/26/2026